PPARG and pulmonary fibrosis: For example, metformin, an oral hypoglycemic drug, with strong properties as an antioxidant and anti-inflammatory molecule, attenuates lung fibrosis by inhibiting TGF-β1 signaling, modulating metabolic pathways, inducing lipogenic differentiation of fibroblasts and activating PPARG [170].